BACKGROUND: There has been increasing concern of metal-on-metal (MOM) hip replacements regarding adverse reactions to metal debris. Information regarding prevalence and risk factors for these adverse reactions is scarce. QUESTIONS/PURPOSES: The primary purposes of our study were to determine (1) the prevalence of adverse reactions to metal debris among patients who received small-headed (< 50 mm) Articular Surface Replacement (ASR™) prostheses in hip resurfacing procedures or the ASR™ XL prostheses during THAs at our institution, and (2) the risk factors for adverse reactions to metal debris and if they are different in hip resurfacing replacements compared with THAs? METHODS: Small-headed ASR™ prostheses were used in 482 operations (424 patients) at our institution. After the recall of ASR™ prostheses, we established a systematic screening program to find patients with adverse reactions to metal debris. At a mean of 4.9 years (range, 0.2-8.1 years) postoperatively, 379 patients (435 hips) attended a screening program, which consisted of clinical evaluation, whole blood cobalt and chromium measurements, and cross-sectional imaging. RESULTS: At followup, 162 hips (34%) have been revised. The majority (85%) were revised owing to causes related to adverse reactions to metal debris. The 7-year survivorship was 51% for the ASR™ hip replacement cohort and 38% for the ASR™ XL THA cohort, respectively. Reduced cup coverage was an independent risk factor for adverse reactions to metal debris in both cohorts. High preoperative ROM, use of the Corail(®) stem, and female gender were associated with an increased risk of adverse reactions to metal debris only in patients undergoing THA. CONCLUSIONS: Adverse reactions to metal debris are common with small-headed ASR™ prostheses. Risk factors for these adverse reactions differ between hip resurfacing procedures and THAs. Our results suggest a more complicated failure mechanism in THAs than in hip resurfacing procedures.
BACKGROUND: There has been increasing concern of metal-on-metal (MOM) hip replacements regarding adverse reactions to metal debris. Information regarding prevalence and risk factors for these adverse reactions is scarce. QUESTIONS/PURPOSES: The primary purposes of our study were to determine (1) the prevalence of adverse reactions to metal debris among patients who received small-headed (< 50 mm) Articular Surface Replacement (ASR™) prostheses in hip resurfacing procedures or the ASR™ XL prostheses during THAs at our institution, and (2) the risk factors for adverse reactions to metal debris and if they are different in hip resurfacing replacements compared with THAs? METHODS: Small-headed ASR™ prostheses were used in 482 operations (424 patients) at our institution. After the recall of ASR™ prostheses, we established a systematic screening program to find patients with adverse reactions to metal debris. At a mean of 4.9 years (range, 0.2-8.1 years) postoperatively, 379 patients (435 hips) attended a screening program, which consisted of clinical evaluation, whole blood cobalt and chromium measurements, and cross-sectional imaging. RESULTS: At followup, 162 hips (34%) have been revised. The majority (85%) were revised owing to causes related to adverse reactions to metal debris. The 7-year survivorship was 51% for the ASR™ hip replacement cohort and 38% for the ASR™ XL THA cohort, respectively. Reduced cup coverage was an independent risk factor for adverse reactions to metal debris in both cohorts. High preoperative ROM, use of the Corail(®) stem, and female gender were associated with an increased risk of adverse reactions to metal debris only in patients undergoing THA. CONCLUSIONS: Adverse reactions to metal debris are common with small-headed ASR™ prostheses. Risk factors for these adverse reactions differ between hip resurfacing procedures and THAs. Our results suggest a more complicated failure mechanism in THAs than in hip resurfacing procedures.
Authors: Antti Eskelinen; Ville Remes; Ilkka Helenius; Pekka Pulkkinen; Juha Nevalainen; Pekka Paavolainen Journal: Acta Orthop Date: 2005-02 Impact factor: 3.717
Authors: Catherine Van Der Straeten; George Grammatopoulos; Harinderjit S Gill; Alessandro Calistri; Patricia Campbell; Koen A De Smet Journal: Clin Orthop Relat Res Date: 2013-02 Impact factor: 4.176
Authors: Kevin J Bozic; Steven Kurtz; Edmund Lau; Kevin Ong; Vanessa Chiu; Thomas P Vail; Harry E Rubash; Daniel J Berry Journal: J Bone Joint Surg Am Date: 2009-07 Impact factor: 5.284
Authors: Adolph V Lombardi; Keith R Berend; Michael J Morris; Joanne B Adams; Michael A Sneller Journal: Clin Orthop Relat Res Date: 2014-11-04 Impact factor: 4.176
Authors: Rami Madanat; Daniel K Hussey; Gabrielle S Donahue; Hollis G Potter; Robert Wallace; Charles Bragdon; Orhun Muratoglu; Henrik Malchau Journal: Clin Orthop Relat Res Date: 2015-08-27 Impact factor: 4.176
Authors: Olli Lainiala; Aleksi Reito; Petra Elo; Jorma Pajamäki; Timo Puolakka; Antti Eskelinen Journal: Clin Orthop Relat Res Date: 2015-01-27 Impact factor: 4.176
Authors: Gabrielle S Donahue; Viktor Lindgren; Vincent P Galea; Rami Madanat; Orhun Muratoglu; Henrik Malchau Journal: Clin Orthop Relat Res Date: 2016-04-27 Impact factor: 4.176